Brain Metastasis:
Estimated 10 to 15% of individuals with stage IV breast cancer have brain metastases. The probability of brain metastasis is typically higher in individuals with a bit more aggressive subtypes of disease such as HER2 +Ve or TNBC.
Brain Metastasis Symptoms:
For maximum individuals with metastatic breast cancer (stage IV breast cancer) that have progressed to the brain, the disease has already reached other organs of the body (lungs/liver/bones). But for roughly 17 percent of individuals with brain metastasis, breast cancer has only progressed to the brain. The risk or probability of this condition is typically higher in individuals with aggressive subtypes of breast cancer, such as TNBC or HER2 +Ve. Breast cancer symptoms that have progressed to the brain may include:
- headache
- blurred vision
- slurred speech
- balance problems
- dizziness
- memory complications
- seizures
- stroke
- mood or personality changes
Brain Metastasis Diagnosis:
With the help of an MRI scan, often with a contrast solution, a healthcare specialist can specify that breast cancer has progressed to the brain. In rare instances, healthcare specialists consider a biopsy to specify brain metastasis.
Treatment for Brain Metastasis:
Metastatic breast cancer (also named stage IV) in any part of the body is typically treated with systemic medications, which treat the disease throughout the whole body. For brain metastasis, local therapies that mainly target the brain, such as surgery or radiation therapy, are occasionally recommended. Still, brain metastases treatment may be challenging due to the blood-brain barrier. But a targeted therapy drug named Tukysa (tucatinib) is expected to be effective and can be considered for brain metastases.
Targeted Therapies for Brain Metastasis:
Targeted therapies for brain metastasis are treatments that are designed to target specific characteristics of unhealthy cells, such as a protein that helps cancerous cells to grow/progress in a prompt or abnormal way. Targeted therapies like Tukysa 50 mg Tablets or 150 mg tablets are typically known for causing less harm to normal, healthy cells than chemotherapy. Some targeted therapies are designed as antibodies that act like the antibodies developed naturally by the body’s own immune systems. Due to this, they are sometimes known as immune-targeted therapies.
Tukysa in India is yet to be registered by the Indian authorities. The targeted therapy Tukysa (tucatinib) in conjunction with the targeted therapy drug Herceptin (trastuzumab) and the chemotherapy drug Xeloda (capecitabine) has been shown to be promising in treating HER2 +Ve breast cancer that has metastasized to the brain.
Make an inquiry and we will help you calculate the total price to buy TUKYSA (tucatinib capsules) online and have it delivered to a particular location. Order Tukysa from INDIAN PHARMA NETWORK (IPN) if this medication has not been authorized or is not registered in the respective country. To get the best Tukysa 150 mg Tablets price in India, kindly Call/WhatsApp: +91 9310090915 or dial TOLL-FREE: 1800-889-1064.
Reference:
https://www.targetedonc.com/view/new-treatments-emerge-for-brain-metastases-in-her2-metastatic-breast-cancer
